Ny forskning 1 september 2026

Varje dag samlar vi de senast publicerade vetenskapliga studierna om hampa, CBD och cannabis och sammanfattar kort vad var och en undersökte — på svenska och engelska. Alla länkar går till primärkällan (PubMed, Europe PMC eller ClinicalTrials.gov). Sammanfattningarna är neutrala beskrivningar av vad forskarna studerade, inte hälsopåståenden.

Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution

ClinicalTrials.gov (ACTIVE_NOT_RECRUITING) · 2026-08-26 · ClinicalTrials.gov

Svenska: This study will monitor for potential chronic liver injury and liver fibrosis, in participants treated with cannabidiol oral solution.

Wayne State Warriors Marijuana Clinical Research Program: Cannabinoid Adjunct to Prolonged Exposure & Recovery

ClinicalTrials.gov (NOT_YET_RECRUITING) · 2026-08-26 · ClinicalTrials.gov

Svenska: The overall strategy is to recruit veterans with PTSD who report minimal current cannabis use but are interested in or considering therapeutic cannabis to manage mental health symptoms (anxiety, depression, PTSD and/or suicidality).

Reducing Breathlessness With Dronabinol in COPD Patients

ClinicalTrials.gov (ACTIVE_NOT_RECRUITING) · 2026-08-28 · ClinicalTrials.gov

Svenska: This clinical trial examines whether Dronabinol, which contains the synthetic psychoactive compound tetrahydrocannabinol (THC), can alleviate severe breathlessness in patients with severe and very severe chronic obstructive pulmonary disease (COPD).

Psilocybin in the Treatment of Cannabis Use Disorder: A-Proof-of-Concept Study

ClinicalTrials.gov (ACTIVE_NOT_RECRUITING) · 2026-08-31 · ClinicalTrials.gov

Svenska: Cannabis is the most commonly used psychoactive substance in Canada (Lowry \& Corsi, 2020).

Cannabidiol and Vitamin E Compromise the Interfacial Stability of Model Lung Surfactant Lipid Monolayers by Altering Their Thermodynamic and Rheological Properties.

Langmuir · 2026 Aug 25 · PubMed